Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens.

Xi TanTareq Fabian CamachoVirginia T LeBaronLeslie J BlackhallRajesh Balkrishnan

Published in: Breast cancer research and treatment (2017)

Switching from AI to TAM was associated with a high likelihood of opioid use. Opioid use was significantly associated with AET non-adherence and higher risk of mortality in female Medicare beneficiaries with breast cancer even after adjusting for adherence.

Keyphrases

early stage
cardiovascular events
glycemic control
stem cells
young adults
weight loss